The import of Rutoside (Rutin) to France showed a declining trend from 2024, with forecasts reflecting a significant reduction in volume. Starting at 138.62 thousand kilograms in 2024, imports are expected to fall sharply by 2028, reaching 43.73 thousand kilograms. Comparing the data from 2023 to 2024, and onwards, there is a consistent year-on-year decline, indicating a decrease in demand or a shift in supply dynamics. Given the data, the Compound Annual Growth Rate (CAGR), over these five years, highlights a continued decrease in imports.
Future trends to watch for include market developments in alternative sources of Rutoside, potential shifts in international trade policies, and changes in demand driven by the pharmaceutical industry's evolving needs. The continued decline suggests a need for stakeholders to re-evaluate procurement strategies or explore domestic production options.
